Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IMM60 |
Trade Name | |
Synonyms | IMM-60|IMM 60 |
Drug Descriptions |
IMM60 is a synthetic agonist of invariant natural killer T-cells (iNKT) encapsulated in liposomes, which potentially increases antitumor immune response and decreases tumor growth (Journal for ImmunoTherapy of Cancer 2022;10). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
IMM60 | IMM60 | 0 | 1 |
IMM60 + Pembrolizumab | IMM60 Pembrolizumab | 0 | 1 |